New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases
Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.
Exosomes/Extracellular Vesicles
New Trial: Mesenchymal Stem Cell Exosomes for Preventing and Treating Organ Failure After Aortic Dissection Surgery
Researchers in China are testing whether exosomes can help prevent or treat organ failure after aortic dissection surgery.
Stem Cell-Derived Extracellular Vesicles Show Promise for Respiratory Disease
Researchers are exploring whether stem cell-derived extracellular vesicles could offer safer, targeted therapies for respiratory diseases, but technical hurdles remain.
Exosomes Show Promise in Supporting Bone Fracture Healing and Regeneration
Researchers explored how exosomes could boost bone healing and pave the way for new regenerative therapies.
New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease
Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.
NurExone reports enhanced scalability and clinical readiness for upcoming exosome-based clinical trials for neurological conditions
The Israeli regenerative medicine company is moving one step closer to clinical trials for serious neurological indications such as TBI, spinal cord injury, etc.
Stem cell exosomes for spinal cord injury: Preclinical study shows improved motor function and blood flow
NurExone Biologic's exosome product moves one step closer to clinical trials with their latest data, published in Cyotherapy.
New Study: Extracellular Vesicles in Fibrin Gel for Cartilage Repair (Italy)
The Italian researchers will do a 51 person trial with MSC-derived EVs in PRP-derived fibrin gels.
Stem Cell and Exosome Trials are Hoping to Tackle Parkinson’s
In March this year, a ScienceDaily article reported that Mass General is pioneering a Phase 1 clinical trial advancing stem cell therapies for Parkinson's disease. The trial involves reprogramming patients' own stem...
Pandorum teams up with AGC Biologics to make stem cell exosomes for Ulcerative Corneal Blindness
Pandorum and AGC have teamed up to produce Pandorum's flagship exosome product Kuragenx, which they refer to as a 'liquid cornea'. Pandorum says that Kuragenx has demonstrated promising results in the preclinical...
